Moberg Pharma completes tap issue of SEK 85m
STOCKHOLM, June 30, 2016. Moberg Pharma AB (OMX: MOB) has completed a tap issue of SEK 85 million to its outstanding bond loan (ISIN: SE0007953989). The proceeds will be used as part financing of the acquisition of New Skin®, Fiber Choice® and PediaCare® and for general corporate purposes.The tap issue was made at a price of 100.50% of the nominal amount, indicating an interest rate of Stibor 3m + 5.88%. After the tap issue, the total outstanding amount of the Company’s bond loan amounts to SEK 385 million under a framework amount of SEK 600 million. The bond loan is listed on Nasdaq